Antonia Perelló - Concepedia

Author

Antonia Perelló

Vall d'Hebron Hospital Universitari ORCID

Also Known As

A Perelló, A Perelló, A. Perello, A. Perelló, Antonia Perello, Antonia Perelló, Perello A

118

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Vall d'Hebron Hospital Universitari Hospital de Viladecans Hospital Universitari Arnau de Vilanova Hospital Universitario Miguel Servet Hospital General de Tomelloso

About

Antonia Perelló is an author at Vall d'Hebron Hospital Universitari specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.1K
2	Health Sciences	5	5	193
3	Nursing	1	1	141
4	Public Health	1	1	141
5	Social Sciences	1	1	47

Antonia Perelló

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Dyspepsia and Irritable Bowel Syndrome After a Salmonella Gastroenteritis Outbreak: One-Year Follow-up Cohort Study Fermín Mearin, Marc Pérez-Oliveras, Antonia Perelló, Gastroenterology Functional Gastrointestinal DisorderMedicinePathogenesisGastroenterologyTraveler Diarrhea	2005	409
Spontaneous bacterial empyema in cirrhotic patients: A prospective study Xavier Xiol, Josep M. Simón Castellví, Jordi Guardiola, Hepatology PneumothoraxGastroenterologyPathologySepsisEscherichia Coli	1996	226
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03) Michael Gnant, Amylou C. Dueck, Sophie Frantal, Journal of Clinical Oncology	2021	220
TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy Antonia Perelló, Juan Carlos García‐Pagán, Rosa Gilabert, Hepatology	2002	217
Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials Poornima Saha, Meredith M. Regan, Olivia Pagani, Journal of Clinical Oncology Quality Of LifeSurgical OncologyBreast OncologyCancer ManagementGynecology	2017	141
Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry Emilio J. Laserna‐Mendieta, Sergio Casabona, Danila Guagnozzi, Alimentary Pharmacology & Therapeutics	2020	124
Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial Karin Ribi, Weixiu Luo, Jürg Bernhard, Journal of Clinical Oncology	2016	123
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial Eva Ciruelos, Patricia Villagrasa, Tomás Pascual, Clinical Cancer Research	2020	111
GEMOX‐R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large‐cell lymphoma: a phase II study Andrés López, Antonio Gutiérrez, Andrés Palacios, European Journal Of Haematology	2007	110
Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice Emilio J. Laserna‐Mendieta, Sergio Casabona, Edoardo Savarino, Clinical Gastroenterology and Hepatology Real-world PracticeEsophagusAllergyGastroenterologyEosinophilic Disorder	2020	102

Page 1